Theratechnologies Inc T.TH

2021 Insider Buying

[SPCEO1]

The total number of shares purchased so far in 2021 by insiders is 110,325. If you assume a $3.40 average price that is $375,000 worth of THTX stock.

[canadapiet]

......which means 2 times "RIDICULOUS" 1) share price and 2) insider buying......!!!!! CRY (LOL was a long time ago.......)  SPCEO1 - (10/25/2021 10:01:02 AM)  2021 Insider Buying The total number of shares purchased so far in 2021 by insiders is 110,325. If you assume a $3.40 average price that is $375,000 worth of THTX stock.   

[Scioto1]

Does the company have the option to compensate board appointments with with stock and not cash?? When I looked at the the annual report looks like they make pretty good coin to serve on this board. Maybe there would be more incentive if it was paid in stock. Please advise.

[Wino115]

It's a mixture of cash and options granted for free. Prior to the annual meeting I had suggested the same to them. The Chairwomen's reponse was that the options align them with shareholders. In my book, unless you've paid for your ownership and put your own skin-in-the-game, it's a very mild form of alignment.  Management is different, but for Boards, it is often seen as free

[Momo25]

Lack of confidence!!! It's all about that. If the insiders knew they have 1 chance on 100 to quadruple their investment in few month,s then they will buy shares. a lot of shares! Or they are very fool.

[canadapiet]

BIG PHARMA = NOT INTERESTED!!!!! Only my idea The Big Ones are very much interested in ONCOLOGY and NASH/NAFLD. Every B P is looking for deals/BO to fill their pipeline/income. There were allready many small,  medium and big deals done in those markets in the past.  TH is not a young company, so every BP knows their history.  In short, none of them are looking for

[Wino115]

I know your overall view, and we are all entitled to one. But factually, just to correct a bit of your conjecture. Tes & Trog would only fill a commercial gap, they are no longer in the pipeline and are out being sold. But I would agree they aren't big or growing enough for anyone to bother. They are there for THTX to milk over the next few years to help pay the bills.  I think until

[jfm1330]

If some insiders are allowed to buy now, it's because they are not aware of efficacy results in the trial. I am sure that at least Levesque and Marsolais are in blackout and they know they need to to keep thight lips. All people with insider status are not equal when it comes to something like an ongoing open label clinical trial. There is a "need to know" principle at work here